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Abstracts / Biol Blood Marrow Transplant 20 (2014) S165eS183S170severity of HC (P-value>0.05). By quantitative PCR, a viral
etiology for one or more viruses was found in 40 cases (CMV,
HSV& BK). HC was managed with supportive care (blood and
platelet transfusion, hydration and irrigation) in all patients.
4 of the patients required surgical interventions and cys-
tectomy. 4 years Overall survival of patients was 56%. Main
cause of death were sever HC (n¼11) and disease relapse
(n¼9).
Conclusion: HC is caused by the interaction of several
conditions such as donor type and preparative regimen in-
tensity. This study shows that young age correlated with a
lower incidence of severe HC. A prospective study is neces-
sary to clarify the association between clinical factors such as
age in the development of severe HC following HSCT in
children.248
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Introduction: Hematopoietic stem cell transplantation
(HSCT) is considered the only curative treatment ofmalignant
infantile osteopetrosis(MIOP). This study evaluates the
radiologic evolution of skeletal changes after HSCT in children
with MIOP.
Methods: Twelve patients(8 male & 4 female, median age of
14.5 months) with proved MIOP underwent HSCT. Patients
received transplant from relative matched donor(n¼9),
unrelated matched(n¼1), unrelated mismatched cord
blood(n¼1) and HLA-haploidentical relative(n¼1). The
source of stem cell were bone marrow(n¼7), peripheral
blood(n¼4) and cord blood(n¼1). Baseline, 6th and 12th
month post-HSCT whole body bone surveys were per-
formed. All patients survived except one who died at 8
months due to infection.
Results: Baseline corticomedullary differentiation was not
detectable in any patient, however by 6th month it was
perceivable in 3(p-value: 0.25) and by 12th month in 9
patients(p-value: 0.004). Baseline endobone appearance was
seen in long and ﬂat bones of 11 and 12patients, respectively.
Resolution of long bones endobone appearance was seen in
9patients by 6th month(p-value: 0.008). None of 11patients
had endobone appearance by 12th month(p-value: 0.002),
while ﬂat bone endobone appearance was persistent in
10patients at 12th month. By 6th month, signiﬁcant disap-
pearance of rachitic changes in long bones was seen, how-
ever it was persistent in ribs in 11patients. By 12th month,
there was not any evidence of rickets in ribs and long bones
of any patient(P-values<0.005). Of all subjects with baseline
skull base sclerosis, by 6th and 12th month it was persistent in
9(p-value: 0.25) and 5patients(p-value: 0.03) respectively.
The mean metaphysical band to femur length ratio was
signiﬁcantly higher at 6th month compared to the base-
line(7.56  3.66 vs. 2.87  1.25, p-value: 0.001)
Conclusion: This study demonstrated the resolution in
skeletal changes of osteopetrosis after successful HSCT. Long
bones rachitic changes and endobone impression were the
ﬁrst to resolve within 6 months after HSCT.249
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Purpose/Objective(s): Optimal management of pediatric
acute lymphoblastic leukemia (ALL) patients with CNS
involvement remains a challenge, with limited data to guide
treatment. The goal of this study is to evaluate survival and
neurocognitive outcomes among pediatric ALL patients with
CNS involvement who underwent stem cell transplantation
(SCT) and received cranial or craniospinal irradiation in
addition to total body irradiation (TBI) as pre-transplant
preparative regimen according to an institutional protocol.
Materials/Methods: A retrospective analysis was performed
of pediatric ALL patients with CNS involvement who under-
went SCT at our institution between 1986 and 2011. The
Kaplan-Meier method was used to compute estimates of
disease-free survival (DFS). Cox regressionmodels were used
to determine associations of patient and disease character-
istics and treatment methods.
Results: Forty-one pediatric ALL patients underwent SCT
with TBI as a preparative regimen and received additional
cranial or craniospinal irradiation due to CNS involvement.
Median age at diagnosis was 5 years (range 1 to 21 years).
Twenty-six patients were standard-risk by NCI criteria, and
14 were high-risk. Five patients underwent transplant in
ﬁrst complete remission (CR), 25 in CR 2, and 11 in CR 3 or
greater. All patients received a cranial boost; median cranial
dose was 24 Gy (range 18-35.4 Gy). Eighteen patients
received a spinal boost; median spinal dose for these pa-
tients was 18 Gy (range 15-24.6 Gy). Survival analysis from
date of SCT revealed a 1 year DFS of 78%, 2 year 67%, and 5
year 67%. Univariate Cox regression revealed no statistically
signiﬁcant associations; however, omission of a spinal
boost was associated with inferior DFS (HR 3.23, p¼0.14). A
combined CNS and bone marrow relapse prior to transplant
was associated with an inferior DFS (HR 3.64, p¼0.11), as
compared with an isolated CNS relapse. 17/41 patients had
an isolated CNS relapse, and analysis of these patients
revealed a 1 year DFS of 88%, 2 year 81%, and 5 year 74%. A
battery of neurocognitive testing was performed in 16 pa-
tients and at a mean of 4.4 years after transplant, mean
post-transplant overall IQ was 103.7 (range 84-143). Pre
and post-transplant neurocognitive testing in a subset
revealed a mean overall IQ change of +4.8 points (range -1
to +9).
Conclusions: We show that addition of craniospinal irra-
diation to TBI is feasible in the preparative regimen for SCT
in children with CNS leukemia and is associated with
favorable DFS at 5 years post transplant, particularly in
those patients with isolated CNS relapse. The use of cra-
niospinal as opposed to cranial irradiation may be impor-
tant in maximizing disease control. Post-transplant
neurocognitive testing reveals average intelligence. Pre and
post-transplant testing shows no change in IQ scores,
though numbers remain small. CSI plus TBI is worthy of
further protocol investigation.
